CUSIP: G55598109
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,631,823
-
Share change
-
-358,244
-
Total reported value
-
$10,858,000
-
Price per share
-
$0.94
-
Number of holders
-
12
-
Value change
-
-$358,467
-
Number of buys
-
5
-
Number of sells
-
6
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP G55598109:
Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q3 2016
As of 30 Sep 2016,
LOMBARD MED INC - COM (EVAR) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,631,823 shares.
The largest 10 holders included
Invesco Ltd., Abingworth LLP, SV Life Sciences Advisers, LLC, Aisling Capital LLC, Texas Yale Capital Corp., GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, HSBC HOLDINGS PLC, KCG Holdings, Inc., and Advisor Group, Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.